Letters, Testimony & Comments
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission.
Priority...
February 14 2012
December 9, 2011
By Electronic Submission
To the State Intellectual Property Office,
The Biotechnology Industry Organization (BIO) appreciates this...
December 9 2011
October 27, 2011
By electronic submission
Saurabh Vishnubhakat
Attorney Advisor,
Office of Chief Economist
United States Patent and Trademark...
October 27 2011
May 31, 2011
The Biotechnology Industry Organization (BIO) thanks the European Medicines Agency (EMA) for the opportunity to submit comments on the...
May 31 2011
February 25, 2011
Patent Amendment (Human Genes and Biological Materials) Bill 2010
Submission to the Senate Legal and Constitutional Affairs Legislation...
February 25 2011
February 15, 2011
The Biotechnology Industry Organization (BIO) appreciates the opportunity to participate in the Special 301 process and is hopeful that...
February 15 2011
November 22, 2010
RE: Participation of Malaysia in the Trans-Pacific Partnership Trade Negotiations
Dear Ms. Blue:
The Biotechnology Industry...
November 22 2010
October 24, 2010
Dear Governor Fortuño:
In what is currently one of the worst economic recessions to be experienced in our lifetime, the life...
October 24 2010
October 14, 2010
October 14, 2010
To: Members of the Ad Hoc Open-ended Working Group on Access and Benefit-sharing of the Convention on Biological...
October 14 2010
September 29, 2010
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide comments on India’s Department of Industrial...
September 29 2010
May 1, 2010
In response to requests from its members, BIO has developed a formal BIO Policy Statement on Options for Increasing Access to Medicines...
May 1 2010
February 18, 2010
Intellectual Property
Innovation and Chair of the Special 301 Committee
Office of the United States Trade Representative
Washington, D...
February 18 2010
November 3, 2009
Dear Ms. Blue,
This letter is submitted by the Biotechnology Industry Organization (BIO) in response to the request for public comment...
November 3 2009
June 1, 2009
U.S. Department of State
June 1 2009
December 15, 2008
December 15 2008
August 25, 2008
Re: DoH Call for Comments 08/2008
Dear Sir or Madam:
The Biotechnology Industry Organization (BIO) appreciates the opportunity to...
August 25 2008
July 3, 2008
The List of Options on Genetic Resources for Consideration by the Intergovernmental Committee on Genetic Resources, Traditional Knowledge...
July 3 2008
July 3, 2008
Comments of the Biotechnology Industry Organization (BIO) on the Draft Gap Analysis on the Protection of
Traditional Knowledge
July...
July 3 2008
May 8, 2008
BIO's comments to the European Commission
May 8 2008
March 14, 2008
March 14 2008
February 28, 2008
Re: Sugestões ao projeto de lei que dispõe sobre o access tos recursos genéticos e seus derivados
Dear Sir/Madam...
February 28 2008
January 22, 2008
ACCESS AND BENEFIT-SHARING: PEER REVIEW PROCESS FOR ABS STUDIES
COMMENTS OF THE BIOTECHNOLOGY INDUSTRY ORGANIZATION
The...
January 22 2008
January 1, 2008
BIO commends the IGWG for its work on a global strategy and plan of action that, according to its mandate, will aim at "securing an...
January 1 2008
October 17, 2007
COMMENTS OF THE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) ON ISSUES TO BE ADDRESSED BY THE TECHNICAL EXPERTS GROUP ON CONCEPTS, TERMS,...
October 17 2007
October 3, 2007
The Biotechnology Industry Organization (BIO) commends the WHO Intergovernmental Working Group on Public Health, Innovation and...
October 3 2007
August 16, 2007
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide comments on the U.S. Council for International...
August 16 2007
July 31, 2007
July 31 2007
July 31, 2007
July 31 2007
June 22, 2007
I'm writing on behalf of the Biotechnology Industry Organization (BIO) in response to your invitation for public comments on...
June 22 2007
May 23, 2007
The Biotechnology Industry Organization (BIO) submits these comments on the European Medicines Agency’s (EMEA’s) draft...
May 23 2007
October 23, 2006
To: Members of the TRIPS Council, World Trade Organization
From: The Presidents of the Biotechnology Industry Organization, BIOTECanada...
October 23 2006
August 28, 2006
Dear Mr. Tian:
I am writing on behalf of the Biotechnology Industry Organization (BIO) in response to your request for comments on the...
August 28 2006
August 28, 2006
To the State Intellectual Property Office of the People's Republic of China
August 28 2006
January 30, 2006
January 30 2006
February 28, 2005
Comments by BIO; CHMP/437/04
February 28 2005
September 7, 2004
Dear Mr. Simon:
I write on behalf of the Biotechnology Industry Organization (BIO) in response to your request for views of European...
September 7 2004
February 5, 2004
February 5 2004
Re: Review of the Declaration of Helsinki
Dear Sir or Madam:
BIO appreciates the opportunity to comment on the World...
Re: European Food Safety Authority (EFSA) Request for public comments on the “Implications of animal cloning on food safety, animal...
RE: Notice of Public Hearing Concerning China's Compliance with WTO Commitments Written Comments (Federal Register Vol. 71, No. 145...
Every Year...
-of the 57 million people who die, 10.5 million are children under 5 years and 1.5 million are children between the ages...
Government's role in developing solutions for diseases that disproportionately affect developing countries
Introduction:
-...
National Institutes of Health: An International Perspective
NIH Mission:
To uncover new knowledge that will lead to improved public...
Innovation And The Global Research Enterprise
WORLD HEALTH ORGANIZATION
GENEVA—NOVEMBER 2007
THEODORE J. ROUMEL
VICE PRESIDENT...
Letters, Testimony & Comments
February 14 2012
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission.
Priority...
December 9 2011
By Electronic Submission
To the State Intellectual Property Office,
The Biotechnology Industry Organization (BIO) appreciates this...
October 27 2011
By electronic submission
Saurabh Vishnubhakat
Attorney Advisor,
Office of Chief Economist
United States Patent and Trademark...
May 31 2011
The Biotechnology Industry Organization (BIO) thanks the European Medicines Agency (EMA) for the opportunity to submit comments on the...
February 25 2011
Patent Amendment (Human Genes and Biological Materials) Bill 2010
Submission to the Senate Legal and Constitutional Affairs Legislation...
Press Releases
April 5 2012
WASHINGTON, D.C.(April 5, 2012)— Thought leaders from dozens of biotech and pharmaceutical corporations from...
October 5 2011
Washington, D.C. (October 5, 2011) – The Biotechnology Industry Organization (BIO) welcomed the transmission of...
April 28 2011
WASHINGTON, D.C. (Thursday, April 28, 2011) - Biofuel research and development companies will present progress in...
April 21 2011
WASHINGTON, D.C. (Thursday, April 21, 2011) - Corporate leaders will discuss benefits for businesses and consumers...
April 19 2011
WASHINGTON, D.C. (Tuesday, April 19, 2011) - The Biotechnology Industry Organization (BIO) announced today that Dr. J...
Receive our newsletter from BIOtechNow
Business Solutions Sponsor
